Viewing nowCombinationOlmesartan Medoxomil 5/40 mg Tablet
Olmesartan Medoxomil 40mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Dongkuk Pharmaceutical Co., Ltd.

MFDS item code 201600300 · Approved 2016.01.18 · Insurance code 653403520
Improvement of blood pressure control in essential hypertension
This medicine is used to effectively manage blood pressure in patients with essential hypertension when blood pressure control is insufficient with monotherapy of S-Amlodipine (Amlodipine) or Olmesartan Medoxomil.
This medication is taken once daily as a single tablet with water, regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). Dosage adjustments should consider the patient's blood pressure response at intervals of more than 2 weeks. The recommended dosing is as follows: - 2.5/20 mg: For patients whose blood pressure is not adequately controlled with S-Amlodipine 2.5 mg or Olmesartan Medoxomil 20 mg monotherapy.
Safety and efficacy have not been established for pediatric patients under 18 years of age.
This medication can cause serious harm or death to the fetus and newborns, especially during the second and third trimesters of pregnancy. Therefore, it should be discontinued immediately upon confirmation of pregnancy. This medication should not be administered to individuals with allergies to the active ingredients or related components, pregnant women, nursing mothers, patients with severe liver disorders, severe aortic stenosis, biliary obstruction, renal dialysis patients, patients in shock, and certain diabetes patients. In patients with low blood pressure who are deficient in body fluids or salts, hypotension may occur at the beginning of treatment with this medication, so careful monitoring of the patient's condition is necessary, and appropriate measures should be taken if hypotension arises. Vascular dilation may lead to acute hypotension, so special care should be taken in patients with aortic stenosis. Patients with severe obstructive coronary artery disease may have an increased risk of angina or myocardial infarction when taking this medication, so caution is advised. This medication should be administered with caution in heart failure patients, and patients with decreased renal function need careful monitoring. Patients with liver disorders may have slowed metabolism of this medication, so caution is needed when prescribing. This medication can cause various adverse reactions, including dizziness, headache, hypotension, edema, dyspepsia, rash, and others. Particularly, serum potassium levels may increase, hence patients at risk of hyperkalemia should regularly test their serum potassium concentrations. This medication may interact with other drugs; therefore, any other medications being taken must be disclosed to the doctor or pharmacist. This medication should be avoided during pregnancy, and if planning to become pregnant, safe alternative treatments should be discussed. Nursing women should stop breastfeeding or discontinue this medication, as it may cause adverse reactions in the infant. Safety and efficacy have not been established for patients under 18 years of age, hence it is not recommended. Elderly patients may have altered drug metabolism due to decreased renal and hepatic function, so starting at a lower dose and careful monitoring is advisable. In case of overdose, symptoms such as hypotension and tachycardia may appear, and immediate medical attention is required. This medication should be stored out of the reach of children and kept away from moisture, heat, and direct sunlight. It is important to consult a doctor immediately if any adverse symptoms occur during medication use.
Hives, severe swelling (edema), difficulty breathing, palpitations, hypotension, orthostatic hypotension, respiratory distress, headache (severe headache and thunderclap headache), fainting, vascular edema, chest tightness, cold sweat, pallor, severe rash with high fever and blisters, skin peeling, pain in the oral and ocular mucosa, jaundice of skin or eyes, generalized fatigue, seizures, altered consciousness, visual disturbances, paralysis, significantly reduced urine output, generalized severe symptoms
Dizziness, headache, drowsiness, sensory disturbance, sensation loss, nausea, vomiting, dyspepsia, diarrhea, constipation, dry mouth, upper abdominal pain, flushing, fatigue, rash, muscle tension, limb pain, low back pain, increased urination, erectile dysfunction, decreased serum potassium, increased serum creatinine, increased serum uric acid, increased gamma-glutamyl transferase, decreased hemoglobin and hematological values, vascular edema, chronic malabsorption syndrome-like enteropathy, hair loss, itching, gynecomastia
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. A storage temperature between 1 degree Celsius and 30 degrees Celsius at room temperature is recommended. Proper storage will help to maintain the efficacy and safety of the medication for a longer time.
Reddish-brown round film-coated tablet
30 tablets
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 40mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Dongkuk Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil · S-Amlodipine Besylate 2.5 Hydrate
Prescription medication · Combination
Ahn-Guk Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ahn-Guk Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.